Login

Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

March 14-15
Salt Lake | Deer Valley

Early Registration Now Open

Learn More

 

Utah Life Sciences by the Numbers

$21.6B

2022 GDP

182K

Direct/Indrect Jobs in 2022

+50%

Higher Average Employee Earnings in 2022

1,600

Establishments in 2022

Source: Pace, L. and Brandley, A. Economic Impacts of Utah's Life Sciences and Health Care Innovation Industry. Kem C. Gardner Institute, University of Utah, 2023.

Job Growth

Utah's life sciences industry job growth outpaced other states from 2012-2022.

Source: Source: Pace, L. and Brandley, A. Economic Impacts of Utah's Life Sciences and Health Care Innovation Industry. Kem C. Gardner Institute, University of Utah, 2023.

Economic Impact

Utah's medical device industry ranks in the top 10 in the nation in three different economic impact metrics, including industry revenues (#8), payroll (#9), and employment (#9).

Source: The Economic Impact o the Medical Technology Industry: A 2021 satistical update on the contributions of the industry ot national and state economic conditions, Advamed, 2021

BioUtah News

February 22, 2024
BioUtah News
Utah Legislative Recap: February 23, 2024

Funding Requests Life Sciences Initiative – Senator Ann Millner The original initiative requested the legislature provide $7.125M of ongoing funding to higher education in Utah to support the workforce needs of Utah’s Life Sciences industry.  BioUtah has worked closely with Talent Ready Utah, colleges and universities in the state, and other stakeholders to create and […]

February 22, 2024
BioUtah News
EVŌQ Nano Announces That Its Antimicrobial Medical Device Platform Demonstrates Success Against the Leading Cause of Healthcare-Associated Infections

Novel Nanoparticle Platform Shows Efficacy Against Antimicrobial Resistance; Potential to Disrupt the $29 BillionCatheter Market SALT LAKE CITY, Feb. 22, 2024 /PRNewswire/ — EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced its antimicrobial medical device platform has demonstrated effectiveness against the world’s leading pathogens implicated […]

February 22, 2024
BioUtah News
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research

SALT LAKE CITY, UT, February 22, 2024 (BusinessWire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development. With nearly 20 years of experience in R&D, phenotypic drug discovery, and assay and scientific operations, O’Mahony […]

February 22, 2024
BioUtah News
February 22, 2024
BioUtah News
Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees

Recipients’ research focused on melanoma diagnosis, treatment response in advanced NSCLC, and bypassing common hurdles in NSCLC diagnosis and treatment

February 22, 2024
BioUtah News
Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership

Pharma and biotech customers distinguish excellence in capabilities, compatibility, expertise, quality and reliability

February 15, 2024
BioUtah News
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor to its women’s health business unit, effective immediately. Dr. Reed brings nearly 15 years of clinical and academic experience […]

February 15, 2024
BioUtah News
Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

FDA Approval Triggers $225 Million Milestone Payment from Ipsen to Merrimack Merrimack Expects to Hold Special Meeting of Stockholders to Approve Plan of Dissolution in May 2024 Following Approval of Plan of Dissolution, Merrimack Expects to Issue a Liquidating Dividend Currently Estimated to be Between $14.65and $15.35 per Share in the Late Spring or Early […]

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors